KCAS to acquire FlowMetric, LLC to better serve cell and gene therapy programs

Bioanalytical and biomarker services provider KCAS (KS, USA) has announced their acquisition of FlowMetric, LLC (PA, USA) in a move to continue meeting customer demands for outsourced cell and gene therapy programs. Regarding the acquisition, CEO of KCAS John Bucksath commented:  “We are delighted to partner with the FlowMetric team, accelerating our combined offering to support the industries and customers we serve. We are committed to supporting FlowMetric to expand its technical reach, capacity and resources through growth investments... continuing to attract the industry’s top scientific talent and focusing on outstanding customer service and accelerating internationalization through additional acquisitions... The...